Headquartered in Memphis, TN, CrossRoads was founded in 2014 by Glen Coleman, Vernon Hartdegen and Chad Hollis. The Company's mission is to develop and commercialize innovative technologies in the orthopedic extremity sector that improve the operating room experience and patient outcomes through simplicity and accuracy for the surgeon, and sustainability and cost reduction for healthcare institutions. CrossRoads' Active Stabilization® technology is the only technology on the market today to simultaneously offer enhanced stability with continuous compression, optimizing conditions for bone healing in fusion procedures. The Company leverages this technology in a broad range of procedure-specific, sterile-packed implants and instrumentation systems cleared for both lower and upper extremity indications. The Company's EcoSMART® Instrument Service provides customers with gamma sterilized, reusable instruments for every surgical case and post-surgery recovery and processing of those instruments. EcoSMART® reduces the inefficiencies of traditional non-sterile instrument trays and eliminates the waste associated with typical disposable instruments.

 HealthpointCapital sold CrossRoads to the Depuy Synthes company of Johnson & Johnson


IlluminOss Medical is a privately held, commercial stage medical device company focused on designing, developing, and marketing orthopedic fracture repair and stabilization products that leverage its proprietary system. The IlluminOss system is a minimally invasive technology that allows for fracture repair and stabilization through the formation of a patient specific intramedullary implant. Specifically designed for the repair and treatment of poor quality, compromised bone; eg osteoporotic or pathologic. The IlluminOss system utilizes a light curable polymer contained within an expandable balloon catheter to create a patient conforming intramedullary implant for bone stabilization. The revolutionary procedure is made through a small minimally invasive surgical approach, providing patients and clinicians with a fast, patient specific method of orthopedic bone stabilization. The Company currently markets its products in the EU under a CE mark and in the USA under FDA clearance. Founded in 2007, IlluminOss is headquartered in East Providence, RI.